These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1699538)

  • 41. Characterization of galanin receptors in the insulin-secreting cell line Rin m 5F: evidence for coupling with a pertussis toxin-sensitive guanosine triphosphate regulatory protein.
    Lagny-Pourmir I; Amiranoff B; Lorinet AM; Tatemoto K; Laburthe M
    Endocrinology; 1989 May; 124(5):2635-41. PubMed ID: 2468476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1.
    Berthold M; Kahl U; Juréus A; Kask K; Nordvall G; Langel U; Bartfai T
    Eur J Biochem; 1997 Oct; 249(2):601-6. PubMed ID: 9370372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Galanin receptors in the post-mortem human brain. Regional distribution of 125I-galanin binding sites using the method of in vitro receptor autoradiography.
    Köhler C; Chan-Palay V
    Neurosci Lett; 1990 Dec; 120(2):179-82. PubMed ID: 1705678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Galanin--10 years with a neuroendocrine peptide.
    Bedecs K; Berthold M; Bartfai T
    Int J Biochem Cell Biol; 1995 Apr; 27(4):337-49. PubMed ID: 7540497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Galanin receptors in human hypothalamus: biochemical and structural analysis.
    Lorinet AM; Javoy-Agid F; Laburthe M; Amiranoff B
    Eur J Pharmacol; 1994 Sep; 269(1):59-64. PubMed ID: 7530206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
    Wang S; Hashemi T; He C; Strader C; Bayne M
    Mol Pharmacol; 1997 Sep; 52(3):337-43. PubMed ID: 9281594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
    Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
    Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discrimination of galanin receptor subtypes in RINm5F cells by structurally different galanin radioligands.
    Deecher DC; López FJ
    Peptides; 2002 Mar; 23(3):545-53. PubMed ID: 11836005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual action of the neuropeptide galanin on the cytoplasmic free calcium concentration in RIN m5F cells.
    Fridolf T; Ahrén B
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1224-9. PubMed ID: 7682064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and molecular characterization of galanin receptor sites in rat brain.
    Servin AL; Amiranoff B; Rouyer-Fessard C; Tatemoto K; Laburthe M
    Biochem Biophys Res Commun; 1987 Apr; 144(1):298-306. PubMed ID: 2437911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gi2 and Gi3 proteins mediate the inhibition of adenylyl cyclase by galanin in the RINm5F cell.
    McDermott AM; Sharp GW
    Diabetes; 1995 Apr; 44(4):453-9. PubMed ID: 7535266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The age-related increase in galanin binding sites in the rat brain correlates with behavioral impairment.
    Krzywkowski P; Lagny-Pourmir I; Jazat F; Lamour Y; Epelbaum J
    Neuroscience; 1994 Apr; 59(3):599-607. PubMed ID: 7516504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Galanin receptor in plasma membrane of canine small intestinal circular muscle.
    Chen CK; McDonald TJ; Daniel EE
    Am J Physiol; 1994 Jan; 266(1 Pt 1):G113-7. PubMed ID: 7508197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human galanin modulates human colonic motility in vitro. Characterization of structural requirements.
    Katsoulis S; Clemens A; Morys-Wortmann C; Schwörer H; Schaube H; Klomp HJ; Fölsch UR; Schmidt WE
    Scand J Gastroenterol; 1996 May; 31(5):446-51. PubMed ID: 8734340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of insulinoma cell proliferation and insulin accumulation by peptides and second messengers.
    Sjöholm A
    Ups J Med Sci; 1995; 100(3):201-16. PubMed ID: 8808183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptors for gut regulatory peptides.
    Laburthe M; Couvineau A; Amiranoff B; Voisin T
    Baillieres Clin Endocrinol Metab; 1994 Jan; 8(1):77-110. PubMed ID: 7510949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New high affinity peptide antagonists to the spinal galanin receptor.
    Xu XJ; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T
    Br J Pharmacol; 1995 Oct; 116(3):2076-80. PubMed ID: 8640348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors.
    Sullivan KA; Shiao LL; Cascieri MA
    Biochem Biophys Res Commun; 1997 Apr; 233(3):823-8. PubMed ID: 9168941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor.
    Land T; Langel U; Löw M; Berthold M; Undén A; Bartfai T
    Int J Pept Protein Res; 1991 Sep; 38(3):267-72. PubMed ID: 1722197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.